Israeli Pain Clinics Risk Lawsuits for Refusing MMJ Options
September 18th, 2015
The Association for Medical Cannabis Treatment in Israel is threatening to sue pain clinics that refuse to offer medical cannabis to patients, according to Marijuana Politics.
In order to receive medical marijuana for the treatment of pain, patients must undergo treatment at a registered pain clinic for a year and exhaust all other methods of pain control, including opioids and surgical procedures. These appointments can cost well over $1,000 per year with only 7,350 approved patients with cannabis permits.
Despite the exhaustive and expensive process, many pain clinics believe that clients seeking there services are merely going through the motions in order to receive medical marijuana for recreational purposes. Some of these clinics have even started to refuse pain patients that express an interest in medical marijuana through phone messages, window signs, and other warnings.
These warnings prompted the Israeli industry association to threaten lawsuits against these clinics for refusing to treat patients with a legal medicinal option. With many other options being potentially more dangerous, such as morphine or opioids, the group contends that the clinics are holding medical marijuana to an unreasonable standard.
Israel’s Health Ministry announced earlier this year that it would be increasing the number of physicians authorized to recommend medical marijuana without patients needing to be certified through the ministry’s medical cannabis unit. In addition, the government organization announced that medical cannabis access would soon be handled through pharmacies rather than dispensed directly by a small group of growers.
In the end, the move could help even the playing field in the country that originally pioneered medical marijuana with the discovery of THC back in 1964.
Follow Us on Social Media
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating the markets, profiling public and private companies, and developing specific investor audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and publishes industry news, thought leader and executive interviews, and stories on the fluid business and regulatory environment while serving as a leading corporate communications platform for companies operating in the industry.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.